BioAtla, Inc. (BCAB) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts BCAB Hot Sheet
Join SI Premium – FREE
BioAtla, Inc. (NASDAQ: BCAB) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley upgrades CDW on stronger AI-driven server demand
- DOJ Unveils $6.5B Healthcare Fraud Crackdown - WSJ
- DoE Announces Conditional $17.5B Financing to Support Westinghouse Nuclear Reactor Deployment
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
